CareRx Future Growth
Future criteria checks 0/6
CareRx is forecast to grow earnings and revenue by 20.9% and 4.8% per annum respectively while EPS is expected to grow by 111.4% per annum.
Key information
20.9%
Earnings growth rate
111.4%
EPS growth rate
Consumer Retailing earnings growth | 4.6% |
Revenue growth rate | 4.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 30 Oct 2024 |
Recent future growth updates
Recent updates
CareRx (TSE:CRRX) Seems To Use Debt Quite Sensibly
Oct 03Analyst Estimates: Here's What Brokers Think Of CareRx Corporation (TSE:CRRX) After Its Second-Quarter Report
Aug 11Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?
Apr 22Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher
Mar 17CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt
Oct 19What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S
Aug 22CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet
Sep 22These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively
May 14Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden
Jan 21Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?
Mar 15Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares
Feb 08Reflecting on CareRx's (TSE:CRRX) Share Price Returns Over The Last Three Years
Dec 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 408 | N/A | N/A | N/A | 3 |
12/31/2025 | 386 | -5 | N/A | N/A | 6 |
12/31/2024 | 354 | -5 | 24 | 31 | 8 |
6/30/2024 | 367 | -7 | 27 | 34 | N/A |
3/31/2024 | 369 | -4 | 23 | 32 | N/A |
12/31/2023 | 371 | -5 | 19 | 27 | N/A |
9/30/2023 | 374 | -6 | 25 | 33 | N/A |
6/30/2023 | 378 | -7 | 30 | 38 | N/A |
3/31/2023 | 380 | -34 | 16 | 29 | N/A |
12/31/2022 | 382 | -34 | 9 | 22 | N/A |
9/30/2022 | 384 | -34 | -4 | 11 | N/A |
6/30/2022 | 358 | -36 | -5 | 10 | N/A |
3/31/2022 | 311 | -20 | -1 | 8 | N/A |
12/31/2021 | 263 | -23 | 0 | 7 | N/A |
9/30/2021 | 212 | -21 | 2 | 7 | N/A |
6/30/2021 | 187 | -24 | -6 | -3 | N/A |
3/31/2021 | 177 | -29 | -2 | 0 | N/A |
12/31/2020 | 162 | -18 | -2 | 0 | N/A |
9/30/2020 | 148 | -50 | -3 | -1 | N/A |
6/30/2020 | 134 | -47 | -2 | 0 | N/A |
3/31/2020 | 126 | -34 | -1 | 2 | N/A |
12/31/2019 | 125 | -46 | 3 | 6 | N/A |
9/30/2019 | 122 | -19 | -1 | 3 | N/A |
6/30/2019 | 119 | -20 | -2 | 4 | N/A |
3/31/2019 | 117 | -39 | 5 | 9 | N/A |
12/31/2018 | 119 | -35 | 2 | 7 | N/A |
9/30/2018 | 85 | -27 | 8 | 14 | N/A |
6/30/2018 | 97 | -23 | 5 | 12 | N/A |
3/31/2018 | 110 | -3 | N/A | 15 | N/A |
12/31/2017 | 122 | -4 | N/A | 16 | N/A |
9/30/2017 | 168 | -6 | N/A | 14 | N/A |
6/30/2017 | 170 | -3 | N/A | 24 | N/A |
3/31/2017 | 170 | -13 | N/A | 10 | N/A |
12/31/2016 | 167 | -18 | N/A | 2 | N/A |
9/30/2016 | 166 | -21 | N/A | 6 | N/A |
6/30/2016 | 166 | -34 | N/A | 3 | N/A |
3/31/2016 | 164 | -30 | N/A | 20 | N/A |
12/31/2015 | 161 | -35 | N/A | 29 | N/A |
9/30/2015 | 27 | -47 | N/A | 28 | N/A |
6/30/2015 | 60 | -48 | N/A | 22 | N/A |
3/31/2015 | 97 | -49 | N/A | 18 | N/A |
12/31/2014 | 135 | -44 | N/A | 20 | N/A |
9/30/2014 | 301 | -48 | N/A | 23 | N/A |
6/30/2014 | 295 | -43 | N/A | 26 | N/A |
3/31/2014 | 289 | -49 | N/A | 24 | N/A |
12/31/2013 | 281 | -39 | N/A | 20 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CRRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CRRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CRRX's revenue (4.8% per year) is forecast to grow slower than the Canadian market (6.9% per year).
High Growth Revenue: CRRX's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CRRX's Return on Equity is forecast to be high in 3 years time